UBM — Ulisse Biomed Spa Cashflow Statement
0.000.00%
Last trade - 00:00- €28.67m
- €25.78m
- €0.14m
Annual cashflow statement for Ulisse Biomed Spa, fiscal year end - December 31st, millions except per share.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | — | IAS | IAS | IAS | IAS |
| Status: | fx Preliminary | Final | Final | Final | Final |
| Net Income/Starting Line | — | -1.1 | 0.222 | -0.604 | -1.31 |
| Depreciation | |||||
| Non-Cash Items | — | 0.013 | -0.095 | -0.131 | -0.154 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | — | 0.625 | -0.779 | 0.092 | 0.171 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | — | -0.405 | -0.601 | -0.395 | -0.97 |
| Capital Expenditures | — | -0.063 | -0.108 | -0.956 | -0.228 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | -0.097 | -0.001 | -0.002 | 0 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | — | -0.161 | -0.109 | -0.958 | -0.228 |
| Financing Cash Flow Items | — | — | -0.021 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | — | 0.001 | -0.023 | 6.3 | 0.002 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | — | -0.565 | -0.733 | 4.95 | -1.2 |